Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy.
Aina Moll-UdinaLucía Miguel EscuderInés HernanzVíctor Llorenç-BellesAlex FonollosaMiguel Cordero ComaMaite Sainz de la MazaGerard EspinosaJ Jacobo González GuijarroFernando Lopez LopezCarmen Alba LineroMarisa HernándezLucía Martínez CostaDiego Celdrán VivancosLena GiraltJoseba ArtarazPablo Soler BartrinaMargarita Jódar MárquezRosario García de VicuñaCristina EsquinasAlfredo Manuel Adán CiveraPublished in: Ocular immunology and inflammation (2020)
Adalimumab can be safe and efficacious for the treatment of NIU in patients 60 years of age and older.
Keyphrases